About APP Oncology Summit
Location
Marriott Boston Newton 2345 Commonwealth Ave Newton MA 02466
Welcome to the Advanced Practice Providers Oncology Summit, the CE conference devoted to providing the latest developments in the multidisciplinary treatment, practical patient management, and interprofessional care of oncology patients.
Join us for this two-day program in beautiful, historic Boston to earn CE credits and learn the latest clinical and practical strategies to improve care for your oncology patients and communication within your healthcare team.
Course Overview The APP Oncology Summit is a two-day conference designed to provide advanced practice providers (APPs) with the latest evidenced-based strategies to optimize care and outcomes for patients with cancer. This conference is planned with and for advanced practice providers (NPs, PAs, pharmacists, and nurse specialists) and is a collaborative effort of oncology clinicians from multiple organizations in each community.
The APP Oncology Summit offers a unique opportunity for APPs from various healthcare teams in the community to collaborate, learn from each other and national faculty, and share best practices on a range of issues related to the care of cancer patients.
Intended Learners Nurse Practitioners, Physician Assistants, Clinical Nurse Specialists, Oncology Pharmacists, and other healthcare professionals involved in the management of oncology patients.
To REGISTER OR LEARN MORE click here!
Privacy Statement: For online registration, we take precautions to protect your information. When you submit sensitive information via the website, your information is protected both online and offline. In order to use this website, a user must first complete the registration form. During registration, a user is required to give certain information (such as name, email/mailing address and payment information). This information is confidential and will only be used to contact you regarding your registration.
Cancellation Policy: Fees are non-refundable and non-transferable.
Comments